Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission

Journal of Hospital Infection

Volumn 66, Issue 2, 2007, Pages 135-141

  Manzur, A ^a   Vidal, M ^a   Pujol, M ^a   Cisnal, M ^a   Hornero, A ^a   Masuet, C ^a   Pena C ^a   Gudiol, F ^a   Ariza, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Bloodstream infection; Healthcare associated infection; Hospital admission; Meticillin resistance; Meticillin resistant Staphylococcus aureus; S. aureus bacteraemia

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; METICILLIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; FEMALE; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RISK; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; RISK FACTOR; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; BACTEREMIA; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SEX FACTORS; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34249730575     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.03.015     Document Type: Article

References (25)

1. Pujol M., Peña C., Pallares R., Ayats J., Ariza J., and Gudiol F. Risk factors for nosocomial bacteremia due to meticillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 13 (1994) 96-102
2. Dominguez M.A., De Lencastre H., Liñares J., and Tomasz A. Spread and maintenance of a dominant meticillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital. J Clin Microbiol 32 (1994) 2081-2087
3. Johnson L., Bhan A., Pawlak J., Manzor O., and Saravolatz L. Changing epidemiology of community-onset meticillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 24 (2003) 431-435
4. Friedman N., Kaye K., Stout J., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 (2002) 791-797
5. Tambyah P., Habib A., Goh H., and Kumarasinghe G. Community-acquired meticillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated". Infect Control Hosp Epidemiol 24 (2003) 436-438
6. Lesens O., Hansmann Y., Brannigan E., et al. Healthcare associated Staphylococcus aureus bacteremia and the risk for meticillin resistance: is the Centers for Disease Control and Prevention definition for community acquired bacteremia still appropriate?. Infect Control Hosp Epidemiol 26 (2005) 204-209
7. Bradley S.F. Meticillin-resistant Staphylococcus aureus: long-term care concerns. Am J Med 106 (1999) 48-52
8. McNeil S.A., Mody L., and Bradley S.F. Meticillin-resistant Staphylococcus aureus. Management of asymptomatic colonization and outbreaks of infections in long-term care. Geriatrics 57 (2002) 16-27
9. Papia G., Louie M., Tralla A., Johnson C., Collins V., and Simor A.E. Screening high risk patients for meticillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?. Infect Control Hosp Epidemiol 20 (1999) 473-477
10. Wyllie D.H., Peto T.E., and Crook D. MRSA bacteremia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. Br Med J 331 (2005) 992-999
11. Tacconelli E., Venkataraman L., De Girolami P.C., and D'Àgata M.C. Meticillin-resistant Staphylococcus aureus bacteremia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 53 (2004) 474-479
12. Harbarth S., Sax H., Frankhauser-Rodriguez C., Schrenzel J., Agostinho A., and Pittet D. Evaluating the probability of previous unknown carriage of MRSA at hospital admission. Am J Med 119 (2006) 275 e15-23
13. Asencio A, Cantón R, Vaqué J, et al., EPINE Working Group. Nosocomial and community-acquired meticillin-resistant Staphylococcus aureus infections in hospitalized patients (Spain, 1993-2003). J Hosp Infect 63 (2006) 465-471
14. Lee S., Chen K., Ch T., et al. An outbreak of meticillin-resistant Staphylococcus aureus infection related to central venous catheters for hemodialysis. Infect Control Hosp Epidemiol 25 (2004) 678-684
15. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaver M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality related to meticillin-resistant and meticillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2002) 53-59
16. Soriano A., Martinez J.A., Mensa J., et al. Pathogenic significance of meticillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30 (2000) 368-373
17. Cosgrove S., Qi Y., Kaye K., Harbarth S., Karchmer A.W., and Carmeli Y. The impact of meticillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26 (2005) 166-174
18. Melzer M., Eykyn S.J., Gransden W.R., and Chinn S. Is meticillin-resistant Staphylococcus aureus more virulent than meticillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 37 (2003) 1453-1460
19. Roghmann M.C. Predicting meticillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Archs Intern Med 160 (2000) 1001-1004
20. Kim S.H., Park W.B., Lee K.D., et al. Outcome of inappropriate initial antimicrobial treatment in patients with meticillin-resistant Staphylococcus aureus bacteremia. J Antimicrob Chemother 54 (2004) 489-497
21. Lodise T., McKinnon P., Swiderski L., and Ryback M. Outcome analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 36 (2003) 1418-1423
22. Talon D., Woronof-Lemsi M.C., Limat S., et al. The impact of resistance to meticillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 13 (2002) 31-36
23. Blot S., Vandewoude K.H., Hoste E., and Colardyn F. Outcome and attributable mortality in critically ill patients with bacteremia involving meticillin susceptible and meticillin resistant Staphylococcus aureus. Arch Intern Med 162 (2002) 2229-2235
24. Cooper B.S., Medley G.F., Stone S.P., et al. Meticillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA 101 (2004) 10223-10228
25. Harris A., Samore M.H., Lipsitch M., Kaye K.S., Perencevich E., and Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci and Escherichia coli. Clin Infect Dis 34 (2004) 1558-1563